Back to Journals » Patient Preference and Adherence » Volume 17

Real-World Comparison of First-Line Treatment Adherence Between Single-Agent Ibrutinib and Acalabrutinib in Patients with Chronic Lymphocytic Leukemia

Total article views   HTML views PDF downloads Totals
7,016 Dovepress* 6,238+ 86 6,324
PubMed Central* 778 268 1,046
Totals 7,016 354 7,370
*Since 23 August 2023

View citations on PubMed Central and Google Scholar